News

Promotional graphic announcing an NIH Technology Transfer presentation at the Bio Innovation Conference. Learn about non-dilutive funding strategies from Sabarni Chatterjee, Deputy Director of the NIH Office of Technology Transfer. Event takes place October 23, 2026, in Bethesda, Maryland.

Beyond SBIRS: Non-Dilutive Funding Strategies to Advance Your Pipeline and Bottom Line

NIH OTT Deputy Director Sabarni Chatterjee will lead an interactive round table at the Maryland Tech Council’s Bio Innovation Conference focused on how you can receive non-dilutive support from the federal government without writing grants. Topics include: Partnerships providing indirect/in-kind
More
blank new placeholder image

Rare Diseases are Not Rare!

NIH observed rare disease day on 28th February 2019 to build commitment in helping people with rare diseases through research at National Center for Advancing Translational Sciences (NCATS) and Clinical Center (CC). NCATS selected eleven honorable mentions and three winners from nearly fifty
More
blank new placeholder image

NIH Researchers Find Genetic Vulnerability to Menthol Cigarette Use

A research team, led by Dennis Drayna, Ph.D., chief of the Section on Genetics of Communication Disorders at the National Institute on Deafness and Other Communication Disorders (NIDCD), conducted detailed genetic analyses on 1,300 adults. A genetic variant found only in people of African descent
More
blank new placeholder image

Start-up Program 2.0: An Evaluation License Program at NCI

The National Cancer Institute (NCI), through the NCI Technology Transfer Center (TTC), now offers a term-limited, exclusive Start-Up Evaluation Option License to start-up companies developing early-stage vaccine, therapeutic, device, and certain diagnostic technologies. The previous Start-up Program
More